239 related articles for article (PubMed ID: 33105495)
1. Cell Replacement Therapy for Huntington's Disease.
Monk R; Connor B
Adv Exp Med Biol; 2020; 1266():57-69. PubMed ID: 33105495
[TBL] [Abstract][Full Text] [Related]
2. Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons.
Garcia Jareño P; Bartley OJM; Precious SV; Rosser AE; Lelos MJ
Int Rev Neurobiol; 2022; 166():1-48. PubMed ID: 36424090
[TBL] [Abstract][Full Text] [Related]
3. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
[TBL] [Abstract][Full Text] [Related]
4. Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington's disease mice and innervate the striatum.
Holley SM; Reidling JC; Cepeda C; Wu J; Lim RG; Lau A; Moore C; Miramontes R; Fury B; Orellana I; Neel M; Coleal-Bergum D; Monuki ES; Bauer G; Meshul CK; Levine MS; Thompson LM
Mol Ther; 2023 Dec; 31(12):3545-3563. PubMed ID: 37807512
[TBL] [Abstract][Full Text] [Related]
5. Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease.
Kim C; Yousefian-Jazi A; Choi SH; Chang I; Lee J; Ryu H
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830381
[TBL] [Abstract][Full Text] [Related]
6. Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review.
Monk R; Connor B
Cells; 2021 Jun; 10(7):. PubMed ID: 34206228
[TBL] [Abstract][Full Text] [Related]
7. Stem cell transplantation for Huntington's diseases.
Choi KA; Choi Y; Hong S
Methods; 2018 Jan; 133():104-112. PubMed ID: 28867501
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
9. Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models.
Creus-Muncunill J; Ehrlich ME
Neurotherapeutics; 2019 Oct; 16(4):957-978. PubMed ID: 31529216
[TBL] [Abstract][Full Text] [Related]
10. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
Geater C; Hernandez S; Thompson L; Mattis VB
Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
[TBL] [Abstract][Full Text] [Related]
11. Soluble mutant huntingtin drives early human pathogenesis in Huntington's disease.
Miguez A; Gomis C; Vila C; Monguió-Tortajada M; Fernández-García S; Bombau G; Galofré M; García-Bravo M; Sanders P; Fernández-Medina H; Poquet B; Salado-Manzano C; Roura S; Alberch J; Segovia JC; Allen ND; Borràs FE; Canals JM
Cell Mol Life Sci; 2023 Aug; 80(8):238. PubMed ID: 37535170
[TBL] [Abstract][Full Text] [Related]
12. Concise Review: The Use of Stem Cells for Understanding and Treating Huntington's Disease.
Connor B
Stem Cells; 2018 Feb; 36(2):146-160. PubMed ID: 29178352
[TBL] [Abstract][Full Text] [Related]
13. Cell-based therapies for Huntington's disease.
Chen Y; Carter RL; Cho IK; Chan AW
Drug Discov Today; 2014 Jul; 19(7):980-4. PubMed ID: 24631682
[TBL] [Abstract][Full Text] [Related]
14. Huntington's disease: new frontiers for molecular and cell therapy.
Melone MA; Jori FP; Peluso G
Curr Drug Targets; 2005 Feb; 6(1):43-56. PubMed ID: 15720212
[TBL] [Abstract][Full Text] [Related]
15. Human-to-mouse prion-like propagation of mutant huntingtin protein.
Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J
Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146
[TBL] [Abstract][Full Text] [Related]
16. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy.
Carbo M; Brandi V; Pascarella G; Staid DS; Colotti G; Polticelli F; Ilari A; Morea V
Int J Mol Med; 2019 Dec; 44(6):2223-2233. PubMed ID: 31638189
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory Strategies for Huntington's Disease Treatment.
Colpo GD; Rocha NP; Stimming EF; Teixeira AL
CNS Neurol Disord Drug Targets; 2017; 16(8):936-944. PubMed ID: 28606048
[TBL] [Abstract][Full Text] [Related]
19. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology.
Freeman TB; Cicchetti F; Hauser RA; Deacon TW; Li XJ; Hersch SM; Nauert GM; Sanberg PR; Kordower JH; Saporta S; Isacson O
Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13877-82. PubMed ID: 11106399
[TBL] [Abstract][Full Text] [Related]
20. Construction of human 3D striato-nigral assembloids to recapitulate medium spiny neuronal projection defects in Huntington's disease.
Wu S; Hong Y; Chu C; Gan Y; Li X; Tao M; Wang D; Hu H; Zheng Z; Zhu Q; Han X; Zhu W; Xu M; Dong Y; Liu Y; Guo X
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2316176121. PubMed ID: 38771878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
